CroíValve

CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study

Additionally, Martin B. Leon, M.D. Appointed as Chair of its Clinical Advisory Board DUBLIN–(BUSINESS WIRE)– CroíValve, an Irish-U.S. based medical device company with a novel, transcatheter solution for tricuspid regurgitation (TR), today announced initiation of its Early Feasibility Study (EFS) for the DUO™ Tricuspid Coaptation Valve System, following FDA IDE and CMS approval. The TANDEM II trial is a prospective, multi-center, non-randomized single-arm study to … Continue reading CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study

AtriCure

AtriCure Appoints Shlomi Nachman to the Board of Directors

January 04, 2024 08:00 AM Eastern Standard Time MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced it appointed Shlomi Nachman to its Board of Directors. Mr. Nachman’s long and distinguished career in the medical device industry has placed him at the forefront of new … Continue reading AtriCure Appoints Shlomi Nachman to the Board of Directors

Moximed

Moximed Announces Appointment of Dave Amerson to Board of Directors

Amerson has demonstrated commercial leadership of multiple early-stage medical device technologies with nearly $3 billion in transaction value for investors FREMONT, Calif.–(BUSINESS WIRE)–Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced that Dave Amerson has joined the company’s Board of Directors. “I am thrilled to join Moximed’s Board of Directors at this … Continue reading Moximed Announces Appointment of Dave Amerson to Board of Directors

BIVACOR

BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer

HUNTINGTON BEACH, Calif. & HOUSTON & GOLD COAST, Australia–(BUSINESS WIRE)–BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Jim Dillon has been named chief executive officer and a member of its board of directors. “A Total Artificial Heart (TAH) is unique in its complexity and importance as an advanced treatment option for end-stage biventricular heart failure patients. The … Continue reading BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer

HENRY SCHEIN

Henry Schein Appoints Carole T. Faig as New Independent Director

MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that its Board of Directors has appointed Carole T. Faig as an independent director to serve until the 2024 Annual Meeting of Stockholders in May, when she is expected to stand for re-election to the Board by a vote of the Company’s … Continue reading Henry Schein Appoints Carole T. Faig as New Independent Director

Orthofix

Orthofix Names Massimo Calafiore as President and Chief Executive Officer

Value-Building Medical Device Executive with 20-Year Record of Driving Market-Leading Growth Across Orthopedics and Spine Businesses Global Leader with Extensive M&A Integration Expertise and Commercial and Operating Experience Across Key Orthofix Geographies November 28, 2023 07:00 AM Eastern Standard Time LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced today that Massimo Calafiore has been named incoming President and Chief … Continue reading Orthofix Names Massimo Calafiore as President and Chief Executive Officer

Aerin Medical

Derrick Sung Joins Aerin Medical as Chief Financial Officer

A seasoned leader, Sung brings deep finance, capital markets, and strategy experience across the medical device industry November 20, 2023 09:00 AM Eastern Standard Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, announced today that Derrick Sung has been appointed chief financial officer of the … Continue reading Derrick Sung Joins Aerin Medical as Chief Financial Officer

CUTERA

Cutera Appoints Stephana Patton as Chief Legal Officer

November 13, 2023 08:30 AM Eastern Standard Time BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, is pleased to announce the appointment of Stephana Patton, Ph.D., J.D. as Chief Legal Officer, effective November 13, 2023. “Cutera has a well-established leadership position in the aesthetics industry, and I’m excited to be part of the team that … Continue reading Cutera Appoints Stephana Patton as Chief Legal Officer